It was a filing-heavy week, with new S-1s spanning specialty property insurance, preclinical biotech, and a golf shot-tracking platform, plus a cluster of small-cap F-1/F-1A updates setting (or re-setting) terms. On the pricing front, the most substantive “what changed” detail came from a defense-tech issuer that allocated proceeds to pay down a newly put-in-place revolver.
In pre-IPO markets, traders kept leaning into some of the AI/HPC-adjacent paper: Hyperliquid funding on SharonAI stayed steeply positive into week-end, while Polymarket’s SpaceX bracket set continued to price a very specific IPO-day market-cap window.
What's coming
Advasa Holdings (ADBT) was scheduled for Tuesday, Aug. 25 at $10.00, marketing an earned wage access platform called FUKUPE that lets employees access earned wages in real time and integrates with employer HR/payroll systems without requiring employer funding. The company framed defensibility around nine issued patents across the U.S., Japan, and South Korea, with filings in additional jurisdictions, and said the platform is already live in Japan with launches in Indonesia and the UAE in preparation.
How the week's deals went
Lyntris (LYNX) priced its IPO on Aug. 19 at $17.50 (per its 424B4), and IPOScoop reported the deal priced below range and the stock traded down afterward. The filing put hard edges around how the company planned to use the raise: it said it would use proceeds to repay approximately $60.0 million outstanding under a new revolving credit facility, with any remainder for general corporate purposes.
The prospectus also spelled out what the business actually is: a defense technology supplier selling “sense-to-act connectivity solutions” across Maritime Domain Awareness, Air & Missile Defense, and Space ISR & resilient communications, delivered via a mix of sensor architecture, sensor hardware, and data & software. The underwriting group listed in the filing included Evercore, Citi, Guggenheim, BofA Securities, Baird, Raymond James, and William Blair, and the board was listed at 8 members.
Alliance Laundry Holdings (ALH) and Andersen Group (ANDG) both filed final 424B4s this week after their earlier S-1s and priced on Aug. 19 (ALH at $22) and Aug. 20 (ANDG at $16), respectively. The filings’ most useful connective tissue was definitional:
- ALH described a global commercial laundry equipment business selling systems into healthcare, hospitality, laundromats, and communal facilities.
- ANDG described an independent tax/valuation/advisory platform spanning private client, business tax, alternative investment funds, and valuation services in the U.S.
Before they list
SharonAI (SHAZ) kept attracting costly long positioning in the pre-IPO perps market. On Hyperliquid (product xyz:SHAZ) as of Aug. 23, the annualised funding ran at 64.9% (7d) and 50.9% (30d)—in plain terms, traders were paying roughly that annualised rate to hold long exposure versus shorts. (Funding is positioning, not performance.) SHAZ also filed another S-1/A this week (Aug. 20), continuing to describe itself as a holding company operating an AI/HPC cloud platform in Australia while developing U.S. data center assets.
SpaceX pre-IPO signals stayed split between private marks and event odds. A Nasdaq Private Market secondary print dated June 28 carried SpaceX at about $1.674T. Meanwhile, on Polymarket’s IPO-day closing market-cap bracket set (complete bracket family), traders priced:
- “between $2.0T and $2.5T” at Yes 0.945 on $396,337 volume;
- “between $2.5T and $3.0T” at Yes 0.0225 on $1,059,520 volume;
- “less than $1.0T” at Yes 0.0005 on $318,967 volume.
Separately, SpaceX’s perpetual-futures funding on Kraken (PF_SPCXXUSD) was -6.5% annualised (7d) and +7% (30d) as of Aug. 23—near-flat on a month view, slightly net-paid-to-be-short on the week view.
Also this week
Orion180 Insurance Group (OIG) filed publicly on Aug. 20, describing a founder-led specialty insurance group built around a proprietary end-to-end platform called MY180 that aggregates data, automates underwriting/pricing, and runs policy admin and claims. In the S-1, Orion180 said it had written approximately $601 million in managed premiums over the last twelve months ended June 30, 2026, sold 670,000+ policies since inception, and distributed through 14,000+ active independent agents as of June 30, 2026. Structurally, it emphasized a split between “Services Companies” (MGA/claims/other services) and “In-House Fronting Carriers,” and said it reinsures the majority of risk to reinsurance partners while retaining a portion via its own carriers.
HCW Biologics (HCWB) filed on Aug. 20 as a preclinical immunotherapy company centered on inflammaging. The S-1 positioned HCW9218 as its lead molecule, designed to both rejuvenate immune activity and capture TGF-ß to neutralize immunosuppression, with a stated plan to submit an IND for a Phase 1b/2 pancreatic cancer trial (with detailed trial structure laid out in the filing). It also described a broader internal molecule-generation engine via its TOBI (Tissue factOr-Based fusIon) platform, noting “over 30 molecules” developed.
Game Your Game (GYGY) filed on Aug. 21, pitching an AI-based golf performance tracking stack combining GPS shot-tracking hardware and subscription software (including GameGolf KZN AI and a “Smart Caddie”). The filing included historical usage claims—over 140 countries, 36,000+ courses mapped, and 3 million+ rounds recorded since the original platform launch era—while explicitly cautioning that these were illustrative and not internal operating metrics used by management on a periodic basis.
Alzamend Neuro (ALZN) filed on Aug. 21 as a preclinical-stage biopharma targeting neurodegenerative disease (with Alzheimer’s disease as the primary target), reporting 4 employees. The filing leaned heavily on disease-burden context and did not, in the provided extract, detail specific product candidates or proceeds allocation.
Chilwa Minerals (CHWM) amended its F-1 on Aug. 20 for its Chilwa Critical Minerals Project around Lake Chilwa in southern Malawi. The company said it holds three exploration licenses (through subsidiaries) covering 881.0136 km², and cited a 2025 technical report stating the project contains approximately 4.54 Mt of HMS at 4.01% THM content, alongside rare earth element exploration targets and drilling results.
MetaOptics (MOT) “slipped off” the Nasdaq IPO calendar on Aug. 18 after being absent for two consecutive syncs while still scheduled, according to the dataset’s calendar note. The item mattered because the company’s prospectus-level use-of-proceeds outline (in the supplied data) was unusually specific about a U.S. expansion plan: estimated net proceeds of ~$14.3M (or ~$16.8M with over-allotment), with about $7.1M for product development/partnerships (including ~$2.9M for acquisitions/technology), ~$1.8M for AI-powered software/algorithms, and ~$5.4M for working capital and general corporate purposes.
Living Homeopathy International Ltd. withdrew its offering on Aug. 18, per Nasdaq, after previously describing itself as a Hong Kong homeopathy service provider with a sales-and-marketing “mentor-mentee” network.
The agenda
| Symbol | Company | Sector | Price range | Date |
|---|---|---|---|---|
| ADBT | Advasa Holdings, Inc. | Software | $10.00 | Tue, Aug 25 |